日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Putative founder effect of Arg338* AP4M1 (SPG50) variant causing severe intellectual disability, epilepsy and spastic paraplegia: Report of three families

Arg338* AP4M1 (SPG50) 变异体可能具有创始人效应,导致严重智力障碍、癫痫和痉挛性截瘫:三个家族的报告

Becker, Aurélie; Felici, Charlotte; Lambert, Laëtitia; de Saint Martin, Anne; Abi-Warde, Marie-Thérèse; Schaefer, Elise; Zix, Christian; Zamani, Mina; Sadeghian, Saeid; Zeighami, Jawaher; Seifi, Tahereh; Azizimalamiri, Reza; Shariati, Gholamreza; Galehdari, Hamid; Selig, Mareike; Ding, Can; Duerinckx, Sarah; Pirson, Isabelle; Abramowicz, Marc; Clément, Guillemette; Leheup, Bruno; Jonveaux, Philippe; Lefort, Geneviève; Bronner, Myriam; Renaud, Mathilde; Bonnet, Céline

Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate

司帕沙星的药代动力学及其与西沙必利和硫糖铝的相互作用

Zix, J A; Geerdes-Fenge, H F; Rau, M; Vöckler, J; Borner, K; Koeppe, P; Lode, H